Prethrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis

Archives of Neurology

Volumn 56, Issue 8, 1999, Pages 967-971

  Bonduel, Mariana ^a   Sciuccati, Gabriela ^a   Hepner, Mirta ^a   Torres, Aurora Feliú ^a   Pieroni, Graciela ^a   Frontroth, Juan Pablo ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5; PHOSPHOLIPID ANTIBODY; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PROTEIN C; PROTEIN S;

ADOLESCENT; ADULT; ANTITHROMBIN DEFICIENCY; ARTERY THROMBOSIS; ARTICLE; CHILD; CLINICAL FEATURE; DISEASE PREDISPOSITION; FEMALE; HEMOSTASIS; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; RISK FACTOR; STROKE;

ADULT; ARTERIAL OCCLUSIVE DISEASES; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; BRAIN; BRAIN ISCHEMIA; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; HEMOSTASIS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SINUS THROMBOSIS, INTRACRANIAL;

EID: 0032818962     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.8.967     Document Type: Article

References (45)

1. Schoenberg BS, Mellinger JF, Schoenberg DG. Cerebrovascular disease in infants and children. Neurology. 1978;28:763-768.
2. de Veber GA, Adams M, Andrew M. Canadian pediatric ischemic stroke registry. Thromb Haemost. 1995;73:1400.
3. Isler W, Stroke in childhood and adolescence. Eur Neurol. 1984;23:421-424.
4. Barron TF, Gusnard DA, Zimmerman RA, Clancy RR. Cerebral venous thrombosis in neonates and children. Pediatr Neurol. 1992;2:112-117.
5. Brower MC, Rollins N, Roach ES. Basal ganglia and thalamic infarction in children. Arch Neurol. 1996;53:1252-1256.
6. Israels SJ, Seshia SS. Childhood stroke associated with protein C or S deficiency. J Pediatr. 1987;111:562-564.
7. Whitlock JA, Janco RL, Phillips JA III. Inherited hypercoagulable states in children. Am J Pediatr Hemat Oncol. 1989;11:170-173.
8. Roddy SM, Giang DW. Antiphospholipid antibodies and stroke in an infant. Pediatrics. 1991;87:933-935.
9. Dungan DD, Jay MS. Stroke in a early adolescent with systemic lupus erythematosus and coexistent antiphospholipid antibodies. Pediatrics. 1992;90:96-99.
10. Prats JM, Garaizar C, Zuazo E, Lopez J, Piñán MA, Aragües P. Superior sagittal sinus thrombosis in a child with protein S deficiency. Neurology. 1992;42:2303-2305.
11. Devilat M, Toso M, Morales M. Childhood stroke associated with protein C or S deficiency and primary antiphospholipid syndrome. Pediatr Neurol. 1993;9:67-70.
12. Barinagarrementeria F, Cantú Brito C, Izaguirre R, de la Peña A. Progressive intracranial occlusive disease associated with deficiency of protein S: report of two cases. Stroke. 1993;24:1752-1756.
13. Göbel U. Inherited or acquired disorders of blood coagulation in children with neurovascular complications. Neuropediatrics. 1994;25:4-7.
14. Schöning M, Klein R, Krägelon-Mann I, et al. Antiphospholipid antibodies in cerebrovascular ischemia and stroke in childhood. Neuropediatrics. 1994;25:8-14.
15. van Kuijck MAP, Rotteveel JJ, van Oostrom CG, Novakova I. Neurological complications in children with protein C deficiency. Neuropediatrics. 1994;25:16-19.
16. Gouault-Heilmann M, Quetin P, Dreyfus M, et al. Massive thrombosis of venous cerebral sinuses in a 2 year-old boy with a combined inherited deficiency of antithrombin III and protein C [letter]. Thromb Haemost. 1994;72:782-783.
17. Charles PD, Fenichel GM. Sneddon and antiphospholipid antibody syndromes causing bilateral thalamic infarction. Pediatr Neurol. 1994;10:262-263.
18. Angelini L, Ravelli A, Caporali R, Rumi V, Nardocci N, Martini A. High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia. Pediatrics. 1994;94:500-503.
19. Uziel Y, Laxer RM, Blaser S, Andrew M, Scheneider R, Silverman ED. Cerebral vein thrombosis in childhood systemic lupus erythematosus. J Pediatr. 1995; 126:722-727.
20. Seaman DE, Londino AV, Kwoh CK, Medsger TA, Manzi S. Antiphospholipid antibodies in pediatric systemic lupus eryttiematosus. Pediatrics. 1995;96:1040-1045.
21. von Scheven E, Athreya BH, Rose CD, Goldsmith DP, Morton L. Clinical characteristics of antiphospholipid antibody syndrome in children. J Pediatr. 1996;129: 339-345.
22. Kohlhase B, Vielhaber H, Kehl HG, Kececioglu D, Koch HG, Nowak-Göttl U. Thromboembolism and resistance to activated protein C in children with underlying cardiac disease. J Pediatr. 1996;129:677-679.
23. Simioni P, De Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A. Ischemic stroke in young patients with activated protein C resistance: a report of three cases belonging to three different kindred. Stroke. 1995;26:885-890.
24. Nowak-Göttl U, Koch HG, Aschka I, et al. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol. 1996;92: 992-998.
25. Ganesan V, Kelsey H, Cookson J, et al. Activated protein C resistance in childhood stroke [letter]. Lancet. 1996;347:260.
26. de Veber G, MacGregor D, Curtis R, et al. Prethrombotic disorders in a consecutive cohort of infants and children with cerebral thromboembolism: is testing worthwhile? Thromb Haemost. 1997(suppl):397.
27. Laurell CB. Electroimmunoassay. Scand J Clin Lab Invest. 1972;29:21-37.
28. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with thrombosis. J Clin Invest. 1984;74:2082-2088.
29. Dahlback B. Inherited thrombophilia. Blood. 1995;85:607-614.
30. Brandt JT, Triplett DA, Alvin B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants. Thromb Haemost. 1995;74:1185-1190.
31. Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood. 1992;80:1998-2005.
32. Harris EN, Khamashta MA, Hughes GRV. Antiphospholipid antibody syndrome. In: McCarthy DJ, Koopman WJ, eds. Arthritis and Allied Conditions. 12th ed. Philadelphia, Pa: Lea & Febiger; 1991:1201-1212.
33. Riikonen RS, Vahtera EM, Kekomäki RM. Physiological anticoagulants and activated protein C resistance in childhood stroke. Acta Paediatr. 1996;85:242-244.
34. Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia: part 1. Thromb Haemost. 1996;76:651-652.
35. Cushman M, Bhushan F, Bovill E, Tracy R. Plasma resistance to activated protein C in venous and arterial thrombosis. Thromb Haemost. 1994;72:647.
36. Ridker PM, Hennekens CH, Lindpaintner K, et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332:912-917.
37. Kontula K, Ylikorkala A, Miettinen H, et al. Arg 506 Gln factor V mutation (factor V Leiden) In patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost 1995;73:558-560.
38. van der Bom JG, Bots ML, Haverkate F, et al. Reduced response to activated protein C is associated with increased risk for cerebrovascular disease. Ann Intern Med. 1996;125:265-269.
39. Emmerich J, Alhenc-Gelas M, Aillaud MF, et al. Clinical features in 36 patients homozygous for the ARG 506-GLN factor V mutation. Thromb Haemost. 1997; 77:620-623.
40. Andrew M, Brooker L, Mitchell L. Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukemia. Blood Coagul Fibrinolysis. 1994;5(suppl 1):S24-S36.
41. Dolan G, Preston FE. Familial plasminogen deficiency and thromboembolism. Fibrinolysis. 1988;2(suppl 2):26-34.
42. Zöller B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet. 1994;343:1536-1538.
43. Martinelli I, Landi G, Merati G, et al. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost. 1996;75:393-394.
44. Hepner M, Roldán A, Pieroni G, et al. Frequency of factor V Arg506 to Gln mutation (FV Leiden) and activated protein C resistance in blood donors in Argentina: a preliminary study. Thromb Haemost. 1997(suppl):226.
45. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and increase in venous thrombosis. Blood. 1996;88:3698-3703.